Palmitone Isolated from Annona diversifolia Induces an Anxiolytic-Like Effect in Mice

Abstract

The aim of this study was to investigate the behavioral effects of palmitone in the anti-anxiety response in experimental models in mice. In the elevated plus-maze test, palmitone (0.3, 1, 3, 10 and 30 mg/kg, i. p.) lengthened, from 50 % to 199 %, the time spent in the open arm region of the maze at all doses tested, as compared to the vehicle group (P < 0.001). In relation to the rearing activity in the exploratory cylinder, palmitone significantly modified (P < 0.05), in a dose-dependent manner, this activity by decreasing the number of rearings with an effective dose value (ED₅₀) and 95 % confidence limits (CL₅₀) of 0.79 (0.23 - 2.68) mg/kg. In addition, in the hole-board test, nose-poking was also significantly decreased (P < 0.01) in a dose-dependent fashion [ED₅₀ (CL₅₀) = 9.07 (4.51 - 18.26) mg/kg]. Moreover, palmitone at any dose caused no change in motor activity nor disruption in traction performance. In contrast, diazepam, used as reference drug, produced an anxiolytic effect with a significant and dose-dependent decrease in motor coordination accompanied by disruption of the traction performance. Behavioral studies suggest an anti-anxiety effect produced by palmitone, but its neuropharmacological profile differs from that observed for benzodiazepines such as diazepam.

Key words

Annona diversifolia Saff. - Annonaceae - anxiolytic - exploratory behavior - palmitone

References

• 1 Gonzalez-Trujano M E, Navarrete A, Reyes B, Cedillo-Portugal E, Hong E. Anticonvulsant properties and bio-guided isolation of palmitone from leaves of Annona diversifolia Saff.  Planta Med. 2001;  67 136-41
• 2 Gonzalez-Trujano M E, Navarrete C A, Reyes B, Hong E. Some pharmacological effects of the ethanol extract of leaves of Annona diversifolia on the central nervous system in mice.  Phytother Res. 1998;  2 600-2
• 3 Durham N W, Miya T S. A note on a simple apparatus for detecting neurological deficits in rats and mice.  J Am Pharm Assoc. 1957;  46 208-10
• 4 Oliva I, Gonzalez-Trujano M E, Arrieta J, Enciso-Rodriguez R, Navarrete A. Neuropharmacological profile of hydroalcoholic extract of Valeriana edulis ssp. procera roots in mice.  Phytother Res. 2004;  18 290-6
• 5 Lister R G. The use of a plus-maze to measure anxiety in the mouse.  Psychopharmacology. 1987;  92 180-5
• 6 Ugalde M, Reza V, Gonzalez-Trujano M E, Avula B, Khan I A, Navarrete A. Isobolographic analysis of the sedative interaction between six central nervous system depressant drugs and Valeriana edulis hydroalcoholic extract in mice.  J Pharm Pharmacol. 2005;  57 631-9
• 7 Hiller K, Zetler G. Neuropharmacological studies on ethanol extracts of Valeriana officinalis: behavioral and anticonvulsant properties.  Phytother Res. 1996;  10 145-51
• 8 Rolland A, Fleurentin J, Lanhers M C, Younos C, Misslin R, Mortier F. et al . Behavioral effects of the American traditional plant Eschscholzia californica: sedative and anxiolytic properties.  Planta Med. 1991;  57 212-6
• 9 Clark G, Koester A G, Pearson D W. Exploratory behavior in chronic disulfoton poisoning in mice.  Psychopharmacologia. 1971;  20 169-71
• 10 Pellow S, File S E. Lack of cross-tolerance in mice between the stimulatory and depressant actions of novel anxiolytics in the holeboard.  Behav Brain Res. 1987;  23 159-66
• 11 Kulkarni S K, Reddy D S. Animal behavioral models for testing antianxiety agents.  Methods Find Exp Clin Pharmacol. 1996;  18 219-30
• 12 Lopez-Rubalcava C, Piña-Medina B, Estrada-Reyes R, Heinze G, Martinez-Vazquez M. Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA/benzodiazepine receptor complex. Life Sci, in press
• 13 Nutt D J, Taylor S C, Little H J. Optimizing the pentetrazol infusion test for seizure threshold measurement.  J Pharm Pharmacol. 1986;  38 697-8
• 14 Chweh A Y, Swinyard E A, Wolf H H. Pentylenetetrazol may discriminate between different types of benzodiazepine receptors.  J Neurochem. 1983;  41 830-3
• 15 Tallman J F, Thomas J W, Gallager D W. GABAergic modulation of benzodiazepine binding site sensitivity.  Nature. 1978;  274 383-5
• 16 Haefely W E, Facklam M, Schoch P, Martin J R, Bonetti E P, Moreau J L. et al . Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.  Adv Biochem Psychopharmacol. 1992;  47 379-94